Review: taking Coumadin and Colcrys together


Summary

Drug interactions are reported among people who take Coumadin and Colcrys together. This review analyzes the effectiveness and drug interactions between Coumadin and Colcrys. It is created by eHealthMe based on reports of 441 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 101,806 users)

Colcrys

Colcrys has active ingredients of colchicine. It is often used in gout. (latest outcomes from Colcrys 1,797 users)

On Sep, 18, 2016

441 people who take Coumadin, Colcrys are studied.


Number of reports submitted per year:

Coumadin and Colcrys drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Colcrys:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (2 of 2 people)
Colcrys:
  • female: 0.0% - (0 of 0 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Colcrys:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • deep vein thrombosis
  • renal failure
  • pneumonia staphylococcal
  • staphylococcal sepsis
  • thrombocytopenia
  • blood creatine phosphokinase increased
  • muscular weakness
  • myositis
  • diarrhoea
  • vomiting
1 - 6 months:
  • gastrointestinal haemorrhage
  • accidental overdose
  • dyspnoea
  • haemorrhage
  • influenza
  • iron deficiency anaemia
  • renal impairment
  • arthralgia
  • aspartate aminotransferase increased
  • asthenia
6 - 12 months:
  • asthenia
  • dehydration
  • disorientation
  • poor quality sleep
  • salivary gland enlargement
  • syncope
  • ventricular tachycardia
1 - 2 years:
  • accidental overdose
  • depressed level of consciousness
  • diverticulitis intestinal haemorrhagic
  • gamma-glutamyltransferase increased
  • haematemesis
  • haemorrhagic stroke
  • hepatic encephalopathy
  • hyperammonaemia
  • hypoaesthesia
  • influenza
2 - 5 years:
  • dehydration
  • gamma-glutamyltransferase increased
  • gastrointestinal haemorrhage
  • nasal polyps
  • rectal haemorrhage
  • salivary gland enlargement
  • epistaxis
  • asthenia
  • cardiac failure congestive
  • cardiomyopathy
5 - 10 years:
  • accidental overdose
  • influenza
  • pericarditis
  • renal impairment
10+ years:
  • epistaxis
  • pericardial effusion
not specified:
  • dyspnoea
  • diarrhoea
  • international normalised ratio increased
  • fatigue
  • gout
  • cardiac failure congestive
  • malaise
  • nausea
  • fall
  • atrial fibrillation

Most common drug interactions by gender *:

female:
  • dyspnoea
  • diarrhoea
  • international normalised ratio increased
  • fall
  • oedema peripheral
  • malaise
  • renal failure acute
  • chest pain
  • myocardial infarction
  • tremor
male:
  • dyspnoea
  • thrombocytopenia
  • cardiac failure congestive
  • diarrhoea
  • gout
  • deep vein thrombosis
  • renal failure
  • fatigue
  • atrial fibrillation
  • international normalised ratio increased

Most common drug interactions by age *:

10-19:
  • arrhythmia
  • atrial fibrillation
  • bradycardia
  • cardiac arrest
  • convulsion
  • diverticulum
  • extrasystoles
  • hypertensive cardiomyopathy
  • infarction
  • renal failure
20-29:
  • chest pain
  • dyspnoea
  • pulmonary thrombosis
  • death
  • deep vein thrombosis
  • fall
  • limb injury
  • poor peripheral circulation
  • weight decreased
  • wound
30-39:
  • cardiac failure congestive
  • confusional state
  • neuropathy peripheral
  • oedema
  • pulmonary hypertension
  • renal failure acute
40-49:
  • diarrhoea
  • coronary artery disease
  • decreased appetite
  • hypotension
  • international normalised ratio increased
  • joint swelling
  • nausea
  • skin ulcer
  • weight decreased
  • rhabdomyolysis
50-59:
  • dyspnoea
  • abdominal pain upper
  • diarrhoea
  • diverticulitis
  • pyrexia
  • therapeutic response unexpected
  • abdominal pain
  • abdominal pain lower
  • chills
  • death
60+:
  • dyspnoea
  • international normalised ratio increased
  • diarrhoea
  • deep vein thrombosis
  • gout
  • cardiac failure congestive
  • renal failure
  • thrombocytopenia
  • malaise
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Colcrys?

Can you answer these questions?

More questions for: Coumadin, Colcrys

You may be interested in these reviews

More reviews for: Coumadin, Colcrys

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Colcrys (colchicine) is often used to treat gout. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.